Your browser doesn't support javascript.
loading
Borderline personality disorder and the big five: molecular genetic analyses indicate shared genetic architecture with neuroticism and openness.
Streit, Fabian; Witt, Stephanie H; Awasthi, Swapnil; Foo, Jerome C; Jungkunz, Martin; Frank, Josef; Colodro-Conde, Lucía; Hindley, Guy; Smeland, Olav B; Maslahati, Tolou; Schwarze, Cornelia E; Dahmen, Norbert; Schott, Björn H; Kleindienst, Nikolaus; Hartmann, Annette; Giegling, Ina; Zillich, Lea; Sirignano, Lea; Poisel, Eric; Chen, Chi-Hua; Nöthen, Markus M; Mobascher, Arian; Rujescu, Dan; Lieb, Klaus; Roepke, Stefan; Schmahl, Christian; Bohus, Martin; Ripke, Stephan; Rietschel, Marcella; Andreassen, Ole A.
Affiliation
  • Streit F; Central Institute of Mental Health, Department of Genetic Epidemiology in Psychiatry, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. fabian.streit@zi-mannheim.de.
  • Witt SH; Central Institute of Mental Health, Department of Genetic Epidemiology in Psychiatry, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Awasthi S; Central Institute of Mental Health, Center for Innovative Psychiatry and Psychotherapy, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Foo JC; Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany.
  • Jungkunz M; Central Institute of Mental Health, Department of Genetic Epidemiology in Psychiatry, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Frank J; Central Institute of Mental Health, Department of Psychosomatic Medicine and Psychotherapy, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Colodro-Conde L; Section for Translational Medical Ethics, National Center for Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hindley G; Central Institute of Mental Health, Department of Genetic Epidemiology in Psychiatry, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Smeland OB; QIMR Berghofer Medical Research Institute Brisbane, Brisbane, QLD, Australia.
  • Maslahati T; School of Psychology, University of Queensland, Brisbane, QLD, Australia.
  • Schwarze CE; School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.
  • Dahmen N; NORMENT, Centre for Mental Disorders Research, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Schott BH; Psychosis Studies, Institute of Psychiatry, Psychology and Neurosciences, King's College London, 16 De Crespigny Park, London, SE5 8AB, United Kingdom.
  • Kleindienst N; NORMENT, Centre for Mental Disorders Research, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Hartmann A; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Giegling I; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Campus Benjamin Franklin, Charité - Medical Faculty Berlin, Berlin, Germany.
  • Zillich L; Department of Developmental and Biological Psychology, Heidelberg University, Heidelberg, Germany.
  • Sirignano L; Department of Psychiatry and Psychotherapy, University Medical Center, Mainz, Germany.
  • Poisel E; Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany.
  • Chen CH; Leibniz Institute for Neurobiology, Magdeburg, Germany.
  • Nöthen MM; Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany.
  • Mobascher A; Central Institute of Mental Health, Department of Psychosomatic Medicine and Psychotherapy, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Rujescu D; Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
  • Lieb K; Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Roepke S; Central Institute of Mental Health, Department of Genetic Epidemiology in Psychiatry, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Schmahl C; Central Institute of Mental Health, Department of Genetic Epidemiology in Psychiatry, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Bohus M; Central Institute of Mental Health, Department of Genetic Epidemiology in Psychiatry, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Ripke S; Department of Radiology, University of California, San Diego, CA, USA.
  • Rietschel M; Institute of Human Genetics, University Hospital Bonn, Bonn, Germany.
  • Andreassen OA; Department of Psychiatry and Psychotherapy, St. Elisabeth Krankenhaus Lahnstein, Lahnstein, Germany.
Transl Psychiatry ; 12(1): 153, 2022 04 11.
Article in En | MEDLINE | ID: mdl-35411043
ABSTRACT
Both environmental (e.g. interpersonal traumatization during childhood and adolescence) and genetic factors may contribute to the development of Borderline Personality Disorder (BPD). Twin studies assessing borderline personality symptoms/features in the general population indicate that genetic factors underlying these symptoms/features are shared in part with the personality traits of the Five Factor Model (FFM) of personality-the "Big Five". In the present study, the genetic overlap of BPD with the Big Five -Openness to Experience, Conscientiousness, Extraversion, Agreeableness, and Neuroticism- was assessed. Linkage disequilibrium score regression was used to calculate genetic correlations between a genome-wide association study (GWAS) in central European populations on BPD (N = 2543) and GWAS on the Big Five (N = 76,551-122,886, Neuroticism N = 390,278). Polygenic scores (PGS) were calculated to test the association of the genetic disposition for the personality traits with BPD case-control status. Significant positive genetic correlations of BPD were found with Neuroticism (rg = 0.34, p = 6.3*10-5) and Openness (rg = 0.24, p = 0.036), but not with the other personality traits (all | rg | <0.14, all p > 0.30). A cluster and item-level analysis showed positive genetic correlations of BPD with the Neuroticism clusters "Depressed Affect" and "Worry", and with a broad range of Neuroticism items (N = 348,219-376,352). PGS analyses confirmed the genetic correlations, and found an independent contribution of the personality traits to BPD risk. The observed associations indicate a partially shared genetic background of BPD and the personality traits Neuroticism and Openness. Larger GWAS of BPD and the "Big Five" are needed to further explore the role of personality traits in the etiology of BPD.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Borderline Personality Disorder / Psychological Trauma Type of study: Prognostic_studies Limits: Adolescent / Humans Language: En Journal: Transl Psychiatry Year: 2022 Document type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Borderline Personality Disorder / Psychological Trauma Type of study: Prognostic_studies Limits: Adolescent / Humans Language: En Journal: Transl Psychiatry Year: 2022 Document type: Article Affiliation country: Germany